Prognosis

WHO Backs AstraZeneca Vaccine, Says Benefits Outweigh Risks

WHO expert team will report findings after review is complete
Blood clots are known to occur frequently in general

Members of the Dutch Red Cross wait in an area after receiving a dose of the AstraZeneca vaccine in Amsterdam, on Feb. 23.Photographer: Peter Boer/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Corinne Gretler

March 17, 2021 at 1:32 PM UTC

Updated on

March 17, 2021 at 2:33 PM UTC

This article is for subscribers only.

The World Health Organization said AstraZeneca Plc’s Covid-19 vaccine should continue to be administered as the benefits outweigh its risks, the second health authority to endorse the shot in as many days.

A WHO expert group is assessing the latest safety data and will communicate the findings once the review is completed, the organization said in a statement Wednesday.